Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-07 | 2024-09 | 4.53 | N/A | N/A | N/A |
2024-08-08 | 2024-06 | 2.64 | 3.92 | 1.28 | 48.48% |
2024-04-30 | 2024-03 | 2.53 | 2.58 | 0.05 | 1.98% |
2024-02-06 | 2023-12 | 2.47 | 2.49 | 0.02 | 0.81% |
2023-11-02 | 2023-09 | -0.08 | 0.1 | 0.18 | 225.00% |
2023-08-08 | 2023-06 | 1.98 | 2.11 | 0.13 | 6.57% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-10 | Morgan Stanley | Upgrade | Overweight | Overweight |
2023-10-08 | Wells Fargo | Upgrade | Overweight | Overweight |
2023-10-08 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-10-01 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-04 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-04 | Morgan Stanley | Upgrade | Overweight | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-09-15 | ALVAREZ RALPH | Director | 54.25K | Stock Award(Grant) |
2024-08-11 | HAKIM ANAT | General Counsel | 30.48K | Stock Gift |
2024-09-15 | HEDLEY MARY LYNNE | Director | 1.64K | Stock Award(Grant) |
2024-09-15 | JOHNSON KIMBERLY H | Director | 2.69K | Stock Award(Grant) |
2024-09-02 | LILLY ENDOWMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | 96.89M | Sale |
2024-09-15 | LUCIANO JUAN R | Director | 15.81K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-09-29 | Lilly Endowment, Inc | 99.98M | 53.70B | 10.53% |
2023-06-29 | Vanguard Group Inc | 69.92M | 32.79B | 7.37% |
2023-06-29 | Blackrock Inc. | 64.45M | 30.23B | 6.79% |
2023-06-29 | PNC Financial Services Group, Inc. | 51.87M | 24.33B | 5.46% |
2023-06-29 | State Street Corporation | 33.88M | 15.89B | 3.57% |
2023-06-29 | FMR, LLC | 32.80M | 15.38B | 3.46% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 26.65M | 12.50B | 2.81% |
2023-06-29 | Vanguard 500 Index Fund | 18.76M | 8.80B | 1.98% |
2023-06-29 | Vanguard/Primecap Fund | 13.35M | 6.26B | 1.41% |
2023-05-30 | Fidelity 500 Index Fund | 8.83M | 3.79B | 0.93% |
2023-08-30 | SPDR S&P 500 ETF Trust | 8.68M | 4.81B | 0.91% |
2023-08-30 | iShares Core S&P 500 ETF | 7.37M | 4.08B | 0.78% |
Dividend | Date |
---|---|
1.3 | 2024-08-15 |
1.3 | 2024-05-15 |
1.3 | 2024-02-15 |
1.3 | 2024-02-14 |
1.13 | 2023-11-14 |
1.13 | 2023-09-08 |
Split | Date |
---|---|
2 : 1 | 1997-10-16 |
2 : 1 | 1995-12-21 |
2 : 1 | 1989-05-01 |
2 : 1 | 1986-01-30 |
-
980 today
-
1000 today
-
960 today
-
Today 980$
-
1050$ in couple days
-
keep filing reports with SEC on this ticker.
They will eventually shut down the pump theyre doing to dump the endowment fund.
-
Giing 1000$ easy
-
$LLY Wells Fargo names Eli Lilly a top pick
Wells Fargo sees improved supply and tailwinds from key drug trials as growth drivers moving Eli Lilly forward.
The firm listed Eli Lilly as a top pick within its biotechnology coverage universe in a Tuesday note, standing by an overweight rating and a $1,000 per share price target. Wells’ forecast implies more than 8% upside from Monday’s $921.81 close.
hide content
-
Target price 1050$ easy in september
-
940 easy end week
-
$LLY Guggenheim Raised its price target on Club holding Eli Lilly to $1,030 a share from $884 and kept its buy rating. Improved supply of its booming GLP-1 drugs is a key driver of near-term business momentum, analysts said. Rapid advancements to Lilly's drug pipeline, though, is bolstering analysts' confidence that the momentum can be sustained in the future
-
Stock will reach 1000 in 15 days
-
1000$ soon
-
$LLY Idiot Bears, Forward PE is 40
-
BEST OF BREED BITCHES -
Soon over 1.5 trillion company
-
$LLY Relax and wake me at $1,400…
-
$LLY Eli Lilly is a ‘unicorn’ with high growth and low beta, Deutsche Bank says
Eli Lilly’s eye-catching earnings report last week has made shares hard to overlook for Deutsche Bank.
Analyst James Shin upgraded the pharmaceutical stock to buy from hold and raised his price target by $300 to $1,025. Shin’s new target reflects 15% upside from last week’s close.
“LLY’s 2Q24 big beat and raise in our view helped settled some nerves in a volatile macro backdrop,” he said in a Monday note. “We see LLY stock outperforming for its high growth outlook and low beta,” Shin added, while calling the stock a “low beta/high growth unicorn.”
Eli Lilly far exceeded Wall Street expectations for the second quarter and upped its full-year guidance. This performance comes as sales of its popular Mounjaro and Zepbound drugs increase.
Shares climbed more than 1% before the bell on Monday. The stock has surged around 53% in 2024.
— Alex Harring
-
Time to say goodbye.
-
-
ResMed stock cut at Wolfe on Lilly GLP-1 threat (NYSE:RMD)
news.google.com • -
December 20th Options Now Available For Eli Lilly (LLY)
news.google.com • -
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
news.google.com • -
Eli Lilly Stock Up 21% in 6 Months: Time to Add to Your Portfolio?
news.google.com • -
Looking Into Eli Lilly's Recent Short Interest
news.google.com • -
Eli Lilly Stock Up 21% in 6 Months: Time to Add to Your Portfolio?
news.google.com • -
Eli Lilly Stock Up 21% in 6 Months: Time to Add to Your Portfolio?
news.google.com • -
Is Most-Watched Stock Eli Lilly and Company (LLY) Worth Betting on Now?
news.google.com • -
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
news.google.com • -
Lilly Gets FDA Approval for Eczema Drug Ebglyss
zacks.com • -
Morgan Stanley’s Best Stock Picks: 15 Stocks To Own For 2025
news.google.com • -
(LLY) Long Term Investment Analysis
news.google.com • -
Do queasy side effects mean the end of weight-loss drug stock hype?
news.google.com • -
Is Eli Lilly and Company (LLY) an Unstoppable Dividend Stocks to Buy?
news.google.com • -
Eli Lilly and Co (LLY) Stock Price, Trades & News
news.google.com • -
Eli Lilly stock gains as Citi resumes at buy (NYSE:LLY)
news.google.com • -
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
news.google.com • -
NVO Oral Obesity Pill Tops Wegovy; LLY, VKTX, GPCR Stocks Rise
news.google.com • -
Bull of the Day: Eli Lilly (LLY)
news.google.com •